Randomised Controlled TrialtcVNSn = 131

Transcutaneous vagus nerve stimulation has no anti-inflammatory effect in diabetes

Okdahl T, Kufaishi H, Kornum D, Bertoli D, Krogh K, K.Knop F, Hansen CS, Størling J, Rossing P, Brock B, et al.

Scientific Reports · 2024

Key finding

Transcutaneous cervical VNS did not reduce plasma concentrations of inflammatory cytokines (IL-6, IL-8, IL-10, TNF-alpha, IFN-gamma) in patients with diabetes over 56 days of treatment.

Condition
Inflammation
Stimulation
tcVNS
Evidence tier
Randomised Controlled Trial
Participants
131
View on DOI

Cite this study

Okdahl, T., Kufaishi, H., Kornum, D., Bertoli, D., Krogh, K., K.Knop, F., Hansen, C. S., Størling, J., Rossing, P., Brock, B., Drewes, A. M., & Brock, C. (2024). Transcutaneous vagus nerve stimulation has no anti-inflammatory effect in diabetes. Scientific Reports, 14(1). https://doi.org/10.1038/s41598-024-72139-y

Related studies in Inflammation

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.